Skip to main content
DrugPrice

Nurtec ODT

Rimegepant

Generic availableMigraineby Pfizer
$353.00
avg cost per claim
+68.4% year-over-year
$876.0M
Medicare Spending
2,480,000
Total Claims
298,000
Beneficiaries
$2,940.00
Annual Cost/Patient

Why Nurtec ODT Costs $353.00 Per Claim

Nurtec ODT (Rimegepant) is used to treat migraine. According to CMS Medicare Part D spending data, the program spent $876.0M on this drug, covering 298,000 beneficiaries across 2,480,000 claims.

A generic version of this drug is available, which means lower-cost alternatives exist. Patients should ask their pharmacist about generic Rimegepant or talk to their doctor about therapeutic alternatives that may cost less.

Spending on Nurtec ODT increased by +68.4% year-over-year, driven by rapidly growing utilization and potential price increases.

Price Breakdown

Avg cost per claim (30-day)$353.00
Avg annual cost per patient$2,940.00
Total Medicare spending$876.0M
Total claims2,480,000
Beneficiaries298,000

Drug Details

Brand Name
Nurtec ODT
Generic Name
Rimegepant
Active Ingredient
Rimegepant
Manufacturer
Pfizer
Dosage Form
N/A
Route
N/A
Condition
Migraine
FDA Application
BLA125057

Frequently Asked Questions

Nurtec ODT (Rimegepant) costs an average of $353.00 per claim based on Medicare Part D data. The estimated annual cost per patient is $2,940.00. Actual out-of-pocket costs depend on your insurance plan and pharmacy.

Yes, a generic version of Nurtec ODT (Rimegepant) is available. Generic medications typically cost 80-95% less than brand-name drugs. Ask your pharmacist about generic Rimegepant.

Medicare Part D spent $876.0M on Nurtec ODT, covering 298,000 beneficiaries across 2,480,000 claims. This makes it one of the tracked drugs in the Medicare spending dashboard.

Ask your pharmacist about generic Rimegepant, which is typically much cheaper. You can also compare prices at different pharmacies, use prescription discount programs, or ask your doctor about therapeutic alternatives in the same drug class.

Cost data reflects Medicare Part D spending and may not represent retail pharmacy prices. Average cost per claim represents the total drug cost (not patient out-of-pocket) divided by total claims.